Drugs / T roleandomycin

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) TAO — 1969-05-27 fda.gov ↗

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 0 NCT02099240 Comparator Mar 2014 → Nov 2018 osteomyelitis University of Louisville Terminated No outcome recorded Stop: Enrollment

Evidence & citations 9 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as T roleandomycin “T roleandomycin” NCT02099240 ↗
Known as Acetyloleandomycin ChEMBL registry synonym — accepted as the source's own label CHEMBL564085 ↗
Known as NSC-108166 ChEMBL registry synonym — accepted as the source's own label CHEMBL564085 ↗
Known as Oleandomycin (as troleandomycin) ChEMBL registry synonym — accepted as the source's own label CHEMBL564085 ↗
Known as Oleandomycin triacetate ester ChEMBL registry synonym — accepted as the source's own label CHEMBL564085 ↗
Known as Triacetyloleandomycin ChEMBL registry synonym — accepted as the source's own label CHEMBL564085 ↗
Known as Troleandomicina ChEMBL registry synonym — accepted as the source's own label CHEMBL564085 ↗
Known as Troleandomycine ChEMBL registry synonym — accepted as the source's own label CHEMBL564085 ↗
Modality Small molecule — CHEMBL564085 ↗